Correlation of molecular markers including mutations with clinical outcomes in advanced non small cell lung cancer (NSCLC) patients (pts) treated with gefitinib, chemotherapy or chemotherapy and gefitinib in IDEAL and INTACT clinical trials Meeting Abstract

  

Authors:	Lynch, T. J.; Bell, D.; Haber, D.; Johnson, D.; Giaccone, G.; Fukuoka, M.; Kris, M.; Herbst, R.; Krebs, A.; Ochs, J.
Abstract Title:	Correlation of molecular markers including mutations with clinical outcomes in advanced non small cell lung cancer (NSCLC) patients (pts) treated with gefitinib, chemotherapy or chemotherapy and gefitinib in IDEAL and INTACT clinical trials
Meeting Title:	41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	23
Issue:	16 Suppl.
Meeting Dates:	2005 May 13-17
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2005-06-01
Start Page:	622S
Language:	English
ACCESSION:	WOS:000230326604123
PROVIDER:	wos
DOI:	10.1200/jco.2005.23.16_suppl.7006
Notes:	--- - Meeting Abstract: 7006 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/44748